We are monitoring the impact of COVID-19 on Europe Molecular Cytogenetics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 3094
Share on
Share on

Europe Molecular Cytogenetics Market Research Report - Segmented By Product, Technique, Application, End User & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, & Forecast to 2024

Pulished: February, 2020
ID: 3094
Pages: 178

Europe Molecular Cytogenetics Market Size & Growth (2019 – 2024):

The Size of the Molecular Cytogenetics Market in Europe is valued at USD 490 million in 2019 and is estimated to grow at a CAGR of 11.5 % , to reach USD 840 million by 2024 during the forecast period 2019-2024.

Molecular biology and cytogenetics are the two major fields that are usually studied under the subject of molecular cytogenetics. The study of chromosomes is named as Cytogenetics. Molecular cytogenetics further analyses the genetic variations and alterations using in-situ hybridization techniques.

Increasing instances of inherited & genetic diseases conjoined with the rise in the in-time disease diagnostics are the major factors fuelling the growth of this market in the aforementioned forecast period. The advent of technologically enhanced entire genome screening techniques (which consist of chromosome microarray analysis and multiplex FISH) due to the technological advancements in the cytogenetic techniques, for example, Comparative Genomic Hybridization (CGH) and the Fluorescence in-situ hybridization (FISH).

Rising levels of awareness regarding the CGH techniques in molecular biology is likely to raise patient acceptance and widen the application horizon in molecular diagnostics. In addition, effective cancer diagnosis because of the characterization of novel diagnostic biomarkers coupled with the development of high-resolution, genetic testing platforms that diagnose constitutional and acquired diseases is vital to the growth of this market segment.

Rising cases of various types of cancer coupled with the rising demand for high-throughput diagnostic tools is expected to boost the usage rate of the molecular cytogenetic technologies over the aforementioned forecast period. Personalized medicine segment is poised to widen the therapeutic horizons in delivering enhanced, molecularly guided therapies, and precise monitoring of disease progression thereby leading to the growth of this market segment.

Europe Molecular Cytogenetics Market has been segmented and sub-segmented into the following categories

  • By Product: Kits & Reagents (Testing Kits, Probes, Fluorescent Affinity Reagents, Other Kits & Reagents), Instruments, Consumables, Software & Services.
  • By Technique: Comparative Genomic Hybridization (Array-Based Comparative Genomic Hybridization, Standard Comparative Genomic Hybridization), Fluorescence in Situ Hybridization, In Situ Hybridization, Others.
  • By Application: Genetic Disorders, Cancer, Personalised Medicine, Other Applications.
  • By End User: Clinical & Research Laboratories, Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Others.
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe.

On the basis of the region, the UK is the leading market in this region. Active involvement from social organizations such as the Leukemia & Lymphoma Society and the funding that they provide which presently are nearly 300 research programs for the development of novel techniques used in the diagnosis of cancer. These techniques are estimated to set the market in this region on a high growth trajectory. It commands the second largest market share of 26% globally.

Promising Companies leading the Europe Molecular Cytogenetics Market Profiled in the Report are Affymetrix, Inc, Agilent Technologies, Inc, Illumina, Inc, Abbott Laboratories, Bio-Rad Laboratories, Inc, Applied Spectral Imaging, Inc, Thermo Fisher Scientific (Life Technologies), Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Kits & Reagents     

                                                5.1.1.1 Testing Kits

                                                5.1.1.2 Probes

                                                5.1.1.3 Fluorescent Affinity Reagents

                                                5.1.1.4 Other Kits & Reagents

                                5.1.2 Instruments           

                                5.1.3 Consumables         

                                5.1.4 Software & Services            

                                5.1.5  Y-o-Y Growth Analysis, By Product              

                                5.1.6  Market Attractiveness Analysis, By Product            

                                5.1.7  Market Share Analysis, By Product              

                5.2 Technique                   

                                5.2.1 Comparative Genomic Hybridization           

                                                5.2.1.1 Array-Based Comparative Genomic Hybridization

                                                5.2.1.2 Standard Comparative Genomic Hybridization

                                5.2.2 Fluorescence in Situ Hybridization

                                5.2.3 In Situ Hybridization            

                                5.2.4 Other Techniques

                                5.2.5 Y-o-Y Growth Analysis, By Technique          

                                5.2.6 Market Attractiveness Analysis, By Technique        

                                5.2.7 Market Share Analysis, By Technique          

                5.3 Application                 

                                5.3.1 Genetic Disorders

                                5.3.2 Cancer      

                                5.3.3 Personalised Medicine      

                                5.3.4 Other Applications               

                                5.3.5 Y-o-Y Growth Analysis, By Application         

                                5.3.6  Market Attractiveness Analysis, By Application      

                                5.3.7  Market Share Analysis, By Application       

                5.4 End User                      

                                5.4.1 Clinical & Research Laboratories    

                                5.4.2 Academic Research Institutes         

                                5.4.3 Pharmaceutical and Biotechnology Companies       

                                5.4.4 Other End Users   

                                5.4.5 Y-o-Y Growth Analysis, By End User             

                                5.4.6  Market Attractiveness Analysis, By End User          

                                5.4.7  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Technique

                                                6.1.3.4 By Application

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Technique

                                                6.1.4.4 By Application

                                                6.1.4.5 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Technique

                                                6.1.5.4 By Application

                                                6.1.5.5 By End User

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 F. Hoffmann-La Roche Ltd. (Switzerland)                      

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Danaher Corporation (U.S.)                 

                8.3 Thermo Fisher Scientific                        

                8.4 Inc. (U.S.)                    

                8.5 Abbott Laboratories (U.S.)                   

                8.6 Agilent Technologies (U.S.)                 

                8.7 PerkinElmer, Inc. (U.S.)                         

                8.8 Illumina, Inc. (U.S.)                  

                8.9 Bio-Rad Laboratories (U.S.)                 

                8.10 Oxford Gene Technology (U.K.)                      

                8.11 Applied Spectral Imaging (U.S.)                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Molecular Cytogenetics Market By Product & Service, From 2019-2024 ( USD Million )
  2. Europe Kits and Reagents Market By Region, From 2019-2024 ( USD Million )
  3. Europe Testing Kits Market By Region, From 2019-2024 ( USD Million )
  4. Europe Probes Market By Region, From 2019-2024 ( USD Million )
  5. Europe Fluorescent Affinity Reagents Market By Region, From 2019-2024 ( USD Million )
  6. Europe Instruments Market By Region, From 2019-2024 ( USD Million )
  7. Europe Consumables Market By Region, From 2019-2024 ( USD Million )
  8. Europe Software and Services Market By Region, From 2019-2024 ( USD Million )
  9. Europe Molecular Cytogenetics Market By Technology, From 2019-2024 ( USD Million )
  10. Europe Comparative Genomic Hybridization (CGH) Market By Region, From 2019-2024 ( USD Million )
  11. Europe Array-based CGH Market By Region, From 2019-2024 ( USD Million )
  12. Europe Standard CGH Market By Region, From 2019-2024 ( USD Million )
  13. Europe Florescence In Situ Hybridization (FISH) Market By Region, From 2019-2024 ( USD Million )
  14. Europe In Situ Hybridization (ISH) Market By Region, From 2019-2024 ( USD Million )
  15. Europe Other Techniques Market By Region, From 2019-2024 ( USD Million )
  16. Europe Molecular Cytogenetics Market By Application, From 2019-2024 ( USD Million )
  17. Europe Genetic Disorders Market By Region, From 2019-2024 ( USD Million )
  18. Europe Cancer Market By Region, From 2019-2024 ( USD Million )
  19. Europe Personalized Medicine Market By Region, From 2019-2024 ( USD Million )
  20. Europe Other Applications Market By Region, From 2019-2024 ( USD Million )
  21. Europe Molecular Cytogenetics Market By End User, From 2019-2024 ( USD Million )
  22. Europe Clinical and Research Laboratories Market By Region, From 2019-2024 ( USD Million )
  23. Europe Academic Research Institutes Market By Region, From 2019-2024 ( USD Million )
  24. Europe Pharmaceutical and Biotechnology Companies Market By Region, From 2019-2024 ( USD Million )
  25. Europe Others End Users Market By Region, From 2019-2024 ( USD Million )
  26. U.K. Molecular Cytogenetics Market By Product & Service, From 2019-2024 ( USD Million )
  27. U.K. Molecular Cytogenetics Market By Technology, From 2019-2024 ( USD Million )
  28. U.K. Molecular Cytogenetics Market By Application, From 2019-2024 ( USD Million )
  29. U.K. Molecular Cytogenetics Market By End User, From 2019-2024 ( USD Million )
  30. Germany Molecular Cytogenetics Market By Product & Service, From 2019-2024 ( USD Million )
  31. Germany Molecular Cytogenetics Market By Technology, From 2019-2024 ( USD Million )
  32. Germany Molecular Cytogenetics Market By Application, From 2019-2024 ( USD Million )
  33. Germany Molecular Cytogenetics Market By End User, From 2019-2024 ( USD Million )
  34. France Molecular Cytogenetics Market By Product & Service, From 2019-2024 ( USD Million )
  35. France Molecular Cytogenetics Market By Technology, From 2019-2024 ( USD Million )
  36. France Molecular Cytogenetics Market By Application, From 2019-2024 ( USD Million )
  37. France Molecular Cytogenetics Market By End User, From 2019-2024 ( USD Million )
  38. Italy Molecular Cytogenetics Market By Product & Service, From 2019-2024 ( USD Million )
  39. Italy Molecular Cytogenetics Market By Technology, From 2019-2024 ( USD Million )
  40. Italy Molecular Cytogenetics Market By Application, From 2019-2024 ( USD Million )
  41. Italy Molecular Cytogenetics Market By End User, From 2019-2024 ( USD Million )
  42. Spain Molecular Cytogenetics Market By Product & Service, From 2019-2024 ( USD Million )
  43. Spain Molecular Cytogenetics Market By Technology, From 2019-2024 ( USD Million )
  44. Spain Molecular Cytogenetics Market By Application, From 2019-2024 ( USD Million )
  45. Spain Molecular Cytogenetics Market By End User, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample